The Neutralization of the Eosinophil Peroxidase Antibody Accelerates Eosinophilic Mucin Decomposition
Cells · 30.11.2023 · 12 (23) · 2746
DOI: 10.3390/cells12232746 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 30.11.2023. Verfasst von Yoshiki Kobayashi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Airway Disease Section, Department of Otorhinolaryngology, Kansai Medical University, Osaka 573-1010, Japan. Hauptthemen laut MEDLINE: Eosinophil Peroxidase, Eosinophilia, Mucins, Sinusitis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grants-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology of Japan, Ministry of Education, Culture, Sports, Science and Technology of Japan.
Abstract (Originalsprache)
Eosinophilic airway inflammation, complicated by bronchial asthma and eosinophilic chronic rhinosinusitis (ECRS), is difficult to treat. The disease may become refractory when eosinophilic mucin associated with eosinophil peroxidase (EPX) and autoantibodies fills in the paranasal sinus and small airway. This study investigated the functional role of an anti-EPX antibody in eosinophilic mucin of ECRS in eosinophilic airway inflammation. Eosinophilic mucin was obtained from patients with ECRS. The effects of the anti-EPX antibody on dsDNA release from eosinophils and eosinophilic mucin decomposition were evaluated. Immunofluorescence or enzyme-linked immunosorbent assays were performed to detect the anti-EPX antibody and its supernatant and serum levels in eosinophilic mucin, respectively. The serum levels of the anti-EPX antibody were positively correlated with sinus computed tomography score and fractionated exhaled nitrogen oxide. Patients with refractory ECRS had higher serum levels of the anti-EPX antibody than those without. However, dupilumab treatment decreased the serum levels of the anti-EPX antibody. Immunoglobulins (Igs) in the immunoprecipitate of mucin supernatants enhanced dsDNA release from eosinophils, whereas the neutralization of Igs against EPX stopped dsDNA release. Furthermore, EPX antibody neutralization accelerated mucin decomposition and restored corticosteroid sensitivity. Taken together, the anti-EPX antibody may be involved in the formulation of eosinophilic mucin and be used as a clinical marker and therapeutic target for intractable eosinophilic airway inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Airway Disease Section, Department of Otorhinolaryngology, Kansai Medical University, Osaka 573-1010, Japan.
- Allergy Center, Kansai Medical University Hospital, Osaka 573-1010, Japan.
ORCID-Profile: Yoshiki Kobayashi, Yasutaka Yun, Akitoshi Mitani, Kensuke Suzuki, Akira Kanda, Hiroshi Iwai
Förderung
- Grants-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology of Japan
- Ministry of Education, Culture, Sports, Science and Technology of Japan
Zitieren
APA
Kobayashi, Y., Chu, H. H., Bui, D. V., Yun, Y., Nguyen, L. M., Mitani, A., Suzuki, K., Asako, M., Kanda, A., & Iwai, H. (2023). The Neutralization of the Eosinophil Peroxidase Antibody Accelerates Eosinophilic Mucin Decomposition. Cells, 12(23), 2746. https://doi.org/10.3390/cells12232746
Vancouver
Kobayashi Y, Chu HH, Bui DV, Yun Y, Nguyen LM, Mitani A, et al. The Neutralization of the Eosinophil Peroxidase Antibody Accelerates Eosinophilic Mucin Decomposition. Cells. 2023;12(23):2746. doi:10.3390/cells12232746
BibTeX
@article{Kobayashi2023,
author = {Kobayashi, Yoshiki and Chu, Hanh Hong and Bui, Dan Van and Yun, Yasutaka and Nguyen, Linh Manh and Mitani, Akitoshi and Suzuki, Kensuke and Asako, Mikiya and Kanda, Akira and Iwai, Hiroshi},
title = {The Neutralization of the Eosinophil Peroxidase Antibody Accelerates Eosinophilic Mucin Decomposition},
journal = {Cells},
year = {2023},
volume = {12},
number = {23},
pages = {2746},
doi = {10.3390/cells12232746}
}
EUVIMED